Autosomal dominant mutations in the catalytic domain of HARS have been associated with CMT2W (7,10,11,22,23), while mutations in the HARS anticodon-binding domain were associated with Usher syndrome type IIIB (USH3B), a disease of progressive hearing and vision loss (24). The gene discussed is HARS1; the disease is Usher syndrome type 3B.